Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

DSpace Repositorium (Manakin basiert)

Molecular testing of rhabdomyosarcoma in clinical trials to improve risk stratification and outcome: A consensus view from European paediatric Soft tissue sarcoma Study Group, Children's Oncology Group and Cooperative Weichteilsarkom-Studiengruppe

Autor(en): Hettmer, Simone; Linardic, Corinne M.; Kelsey, Anna; Rudzinski, Erin R.; Vokuhl, Christian; Selfe, Joanna; Ruhen, Olivia; Shern, Jack F.; Khan, Javed; Kovach, Alexander R.; Lupo, Philip J.; Gatz, Susanne A.; Schaefer, Beat W.; Volchenboum, Samuel; Minard-Colin, Veronique; Koscielniak, Ewa; Hawkins, Douglas S.; Bisogno, Gianni; Sparber-Sauer, Monika; Venkatramani, Rajkumar; Merks, Johannes H. M.; Shipley, Janet
Tübinger Autor(en):
Koscielniak, Ewa
Sparber-Sauer, Monika
Erschienen in: European Journal of Cancer (2022), Bd. 172, S. 367-386
Verlagsangabe: Elsevier Sci Ltd
Sprache: Englisch
Referenz zum Volltext: http://dx.doi.org/10.1016/j.ejca.2022.05.036
ISSN: 0959-8049
DDC-Klassifikation: 610 - Medizin, Gesundheit
Dokumentart: Wissenschaftlicher Artikel
Zur Langanzeige

Das Dokument erscheint in: